These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1643649)

  • 1. Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990.
    Sühnel J
    Cancer Res; 1992 Aug; 52(16):4560-1; author reply 4561-5. PubMed ID: 1643649
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990.
    Berenbaum MC
    Cancer Res; 1992 Aug; 52(16):4558-60; author reply 4561-5. PubMed ID: 1643648
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.
    Greco WR; Park HS; Rustum YM
    Cancer Res; 1990 Sep; 50(17):5318-27. PubMed ID: 2386940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
    Kern DH; Morgan CR; Hildebrand-Zanki SU
    Cancer Res; 1988 Jan; 48(1):117-21. PubMed ID: 3334986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced therapeutic effect of cis-diamminedichloroplatinum(II) against nude mouse grown human pancreatic adenocarcinoma when combined with 1-beta-D-arabinofuranosylcytosine and caffeine.
    Kyriazis AP; Kyriazis AA; Yagoda A
    Cancer Res; 1985 Dec; 45(12 Pt 1):6083-7. PubMed ID: 4063965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of 1-beta-D-arabinofuranosylcytosine and cis-diamminedichloroplatinum in their lethal efficacies against seven established cancer cell lines of gastrointestinal origin.
    Trujillo JM; Yang LY
    Anticancer Res; 1989; 9(1):197-201. PubMed ID: 2705747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitro.
    Howell SB; Gill S
    Cancer Treat Rep; 1986 Mar; 70(3):409-10. PubMed ID: 3955553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of etoposide and cisplatin in an in vitro tumor model.
    Durand RE; Goldie JH
    Cancer Treat Rep; 1987; 71(7-8):673-9. PubMed ID: 3607781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
    Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
    Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of paclitaxel in combination with cisplatin and a new Pt-mercaptopyridine complex.
    Ragazzi E; D'Ancona S; Berti E; Carrara M
    Anticancer Res; 2002; 22(5):2783-8. PubMed ID: 12529997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinum.
    Trujillo JM; Yang LY; Gercovich G; Su YZ; Lee J
    Anticancer Res; 1989; 9(6):1751-6. PubMed ID: 2627125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on biochemical modulation of chemotherapeutic agents.
    Kobayashi K; Schilsky RL
    Oncology (Williston Park); 1993 May; 7(5):99-106, 109; discussion 110-4, 117. PubMed ID: 8512789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the application of response surface methodology in the combination therapy of cancer.
    Carter WH; Wampler GL
    Cancer Treat Rep; 1986 Jan; 70(1):133-40. PubMed ID: 3943113
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
    Futagami M; Sato S; Sakamoto T; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Sep; 82(3):544-9. PubMed ID: 11520153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence Re: L.E. Damon et al., Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res., 51: 4141-4145, 1991.
    Kreis W; Budman DR
    Cancer Res; 1992 Jul; 52(13):3818-20. PubMed ID: 1617654
    [No Abstract]   [Full Text] [Related]  

  • 20. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.